Markets:

Overview

News

Currencies

International

Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

46.06 -1.13 (-2.39%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jun 1, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

3 Unprofitable Stocks We Keep Off Our Radar

January 07, 2026

Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth.

Via StockStory

Dow Jones Erases Record Highs in 200-Point Reversal as Economic Data Shifts

January 07, 2026

The Dow Jones Industrial Average (DJIA) experienced a jarring reversal on Wednesday, January 7, 2026, tumbling more than 200 points after hitting a fresh all-time high earlier in the session. The...

Via MarketMinute

Wall Street Shatters Records: S&P 500 and Dow Hit Historic Intraday Highs Amid AI Surge and Geopolitical Shifts

January 07, 2026

The U.S. stock market entered uncharted territory on Wednesday, January 7, 2026, as the S&P 500 and the Dow Jones Industrial Average both climbed to fresh all-time intraday highs. Driven by a potent...

Via MarketMinute

Topics Artificial Intelligence Economy Government

Moderna’s Second Act: Analyzing the 2026 Pipeline Pivot and Recent Stock Surge

January 07, 2026

Date: January 7, 2026 Introduction Moderna, Inc. (NASDAQ: MRNA), once the definitive poster child of the COVID-19 pandemic response, is currently undergoing one of the most significant pivots in the...

Via PredictStreet

Topics Economy Initial Public Offering Intellectual Property

My Top 5 Stocks to Buy in Early 2026 ↗

January 07, 2026

These companies are leaders in their fields.

Via The Motley Fool

Topics Artificial Intelligence

Uncover the latest developments among S&P500 stocks in today's session. ↗

January 06, 2026

Via Chartmill

These S&P500 stocks are moving in today's session ↗

January 06, 2026

Via Chartmill

Moderna Announces Global Regulatory Submissions for Its Investigational Seasonal Influenza Vaccine

January 05, 2026

Via ACCESS Newswire

Pfizer’s Dividend Trap or Deep Value? Analyzing the Pharma Giant as Shares Languish Below $30

January 01, 2026

As the calendar turns to January 1, 2026, Pfizer Inc. (NYSE: PFE) finds itself in a position that would have been unthinkable during the height of the pandemic. Once the darling of the pharmaceutical...

Via MarketMinute

Topics Intellectual Property

Stay informed with the top movers within the S&P500 index on Wednesday. ↗

December 31, 2025

Via Chartmill

Uncover the latest developments among S&P500 stocks in today's session. ↗

December 31, 2025

Via Chartmill

Discover which S&P500 stocks are making waves on Tuesday. ↗

December 30, 2025

Curious about the S&P500 stocks that are in motion on Tuesday? Join us as we explore the top movers within the S&P500 index during today's session.

Via Chartmill

1 Mooning Stock to Own for Decades and 2 We Find Risky

December 29, 2025

Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or...

Via StockStory

S&P 500 Tests Critical Support: Can the Bull Market Survive the Year-End Pullback?

December 29, 2025

As the sun sets on a historic 2025, the S&P 500 (NYSE:SPY) is facing a moment of technical reckoning. After reaching a breathtaking all-time high of 6,932.05 on Christmas Eve, the index has entered a...

Via MarketMinute

Topics Artificial Intelligence Bonds Earnings

Market Breather: Benchmarks Pause Record-Breaking Year as Volatility Signals Year-End Reset

December 29, 2025

As the final trading days of 2025 approach, the relentless momentum that propelled major U.S. indices to historic heights has entered a period of measured consolidation. After a year defined by the...

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

Forget Moderna Stock, This is a Much Better Buy ↗

December 27, 2025

This stock is a great choice for cautious and aggressive investors.

Via The Motley Fool

Topics Intellectual Property

Discover which S&P500 stocks are making waves on Friday. ↗

December 26, 2025

Stay informed about the performance of the S&P500 index one hour before the close of the markets on Friday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

Uncover the latest developments among S&P500 stocks in today's session. ↗

December 26, 2025

Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Friday.

Via Chartmill

These S&P500 stocks are gapping in today's session ↗

December 26, 2025

Looking for the S&P500 stocks that are experiencing notable gaps on Friday? Find out which stocks are gapping up and gapping down in the S&P500 index during today's session.

Via Chartmill

S&P 500 Scales New Heights: Record-Breaking 2025 Sets the Stage for a High-Stakes 2026

December 26, 2025

The S&P 500 index has concluded 2025 on a historic high, defying early-year skepticism and navigating significant geopolitical shifts to reach unprecedented levels. As of the final full week of trading...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

Pfizer’s 2026 Outlook Misses the Mark as Post-Pandemic Hangover and Patent Cliff Loom

December 25, 2025

NEW YORK — On December 16, 2025, Pfizer (NYSE:PFE) issued a conservative financial outlook for the 2026 fiscal year, falling short of Wall Street’s expectations and signaling a prolonged period of...

Via MarketMinute

Topics Economy Intellectual Property

Moderna (MRNA) Deep-Dive: Navigating the 7.5% Year-End Slide and the Path to a 2028 Recovery

December 24, 2025

As of December 24, 2025, Moderna, Inc. (Nasdaq: MRNA) finds itself at a pivotal crossroads in its corporate evolution. Once the definitive success story of the pandemic era, the Cambridge-based...

Via PredictStreet

Topics Initial Public Offering

Uncover the latest developments among S&P500 stocks in today's session. ↗

December 23, 2025

Let's delve into the developments on the US markets one hour before the close of the markets on Tuesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.

Via Chartmill

These S&P500 stocks are moving in today's session ↗

December 23, 2025

Stay updated with the movements of the S&P500 index in the middle of the day on Tuesday. Discover which stocks are leading as top gainers and losers in today's session.

Via Chartmill

These S&P500 stocks are gapping in today's session ↗

December 23, 2025

Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Tuesday. Discover the gap up and gap down stocks in the S&P500 index.

Via Chartmill

Monday's session: top gainers and losers in the S&P500 index ↗

December 22, 2025

Stay informed about the performance of the S&P500 index one hour before the close of the markets on Monday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

Top S&P500 movers in Monday's session ↗

December 22, 2025

Stay updated with the movements of the S&P500 index in the middle of the day on Monday. Discover which stocks are leading as top gainers and losers in today's session.

Via Chartmill

The Pfizer Pivot: A Deep-Dive into PFE’s 2025 Financial Recovery and Strategic Rebirth

December 22, 2025

As of today, December 22, 2025, Pfizer Inc. (NYSE: PFE) stands as a case study in corporate reinvention and the brutal reality of the post-pandemic "hangover." Once the darling of the global healthcare...

Via PredictStreet

Topics Economy Intellectual Property

Moderna (MRNA): The “Act 2” of an mRNA Pioneer – A 2025 Deep Dive

December 22, 2025

As of December 22, 2025, Moderna, Inc. (NASDAQ: MRNA) stands at a critical juncture in its corporate evolution. Once the poster child for the biotechnology industry’s rapid response to the global...

Via PredictStreet

Topics Earnings Initial Public Offering Intellectual Property

Why Is Moderna (MRNA) Stock Rocketing Higher Today

December 19, 2025

Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 7.8% in the afternoon session after the stock's positive momentum continued as the Coalition for Epidemic Preparedness Innovations (CEPI)...

Via StockStory

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.